It has been shown that although PD-L1 expression in tumor biopsies does appear to predict response to anti-PD-1 therapies, many tumors predicted as PD-L1 positive do not respond, while some responses occur in PD-L1-negative tumors [46–51]. Here, PDCD1 is linked to neoplasm.